Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules

NCT01704846 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: BI 201335 NA 120 mg capsule
DRUG: BI 201335 NA 120 mg capsule
DRUG: BI 201335 NA 40 mg capsule
DRUG: BI 201335 NA 40 mg capsule

Sponsor

Boehringer Ingelheim